Introduction:Basic information about CAS 523-87-5|dimenhydrinate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | dimenhydrinate |
|---|
| CAS Number | 523-87-5 | Molecular Weight | 469.96400 |
|---|
| Density | / | Boiling Point | 343.7ºC at 760 mmHg |
|---|
| Molecular Formula | C24H28ClN5O3 | Melting Point | 102-107ºC |
|---|
| MSDS | USA | Flash Point | 101.5ºC |
|---|
| Symbol | GHS07 | Signal Word | Warning |
|---|
Names
| Name | dimenhydrinate |
|---|
| Synonym | More Synonyms |
|---|
dimenhydrinate BiologicalActivity
| Description | Dimenhydrinate is an anti-emetic and anti-histamine commonly available over-the-counter as a motion sickness remedy. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Histamine ReceptorSignaling Pathways >>Immunology/Inflammation >>Histamine ReceptorNatural Products >>OthersResearch Areas >>Neurological Disease |
|---|
Chemical & Physical Properties
| Boiling Point | 343.7ºC at 760 mmHg |
|---|
| Melting Point | 102-107ºC |
|---|
| Molecular Formula | C24H28ClN5O3 |
|---|
| Molecular Weight | 469.96400 |
|---|
| Flash Point | 101.5ºC |
|---|
| Exact Mass | 469.18800 |
|---|
| PSA | 85.15000 |
|---|
| LogP | 2.96790 |
|---|
| InChIKey | NFLLKCVHYJRNRH-UHFFFAOYSA-N |
|---|
| SMILES | CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O |
|---|
| Storage condition | 2-8°C |
|---|
| Water Solubility | Slightly soluble (0.1-1 g/100 mL at 22 ºC) |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- XH5082000
- CAS REGISTRY NUMBER :
- 523-87-5
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 12
- MOLECULAR FORMULA :
- C17-H21-N-O.C7-H7-Cl-N4-O2
- MOLECULAR WEIGHT :
- 470.02
- WISWESSER LINE NOTATION :
- T56 BM DN FNVNVJ CG F H &622
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - woman
- DOSE/DURATION :
- 100 mg/kg
- TOXIC EFFECTS :
- Brain and Coverings - increased intracranial pressure Behavioral - convulsions or effect on seizure threshold Cardiac - arrhythmias (including changes in conduction)
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - man
- DOSE/DURATION :
- 11400 ug/kg
- TOXIC EFFECTS :
- Behavioral - hallucinations, distorted perceptions
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Human - infant
- DOSE/DURATION :
- 114 mg/kg
- TOXIC EFFECTS :
- Behavioral - convulsions or effect on seizure threshold Behavioral - coma Cardiac - arrhythmias (including changes in conduction)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 1320 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CLDND* Compilation of LD50 Values of New Drugs. (J.R. MacDougal, Dept. of National Health and Welfare, Food and Drug Divisions, 35 John St., Ottawa, Ont., Canada)
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 203 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intraperitoneal
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 149 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intramuscular
- SPECIES OBSERVED :
- Bird - pigeon
- DOSE/DURATION :
- >200 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
MUTATION DATA - TYPE OF TEST :
- Mutation in microorganisms
- TEST SYSTEM :
- Bacteria - Salmonella typhimurium
- DOSE/DURATION :
- 333 ug/plate
- REFERENCE :
- ENMUDM Environmental Mutagenesis. (New York, NY) V.1-9, 1979-87. For publisher information, see EMMUEG. Volume(issue)/page/year: 9(Suppl 9),1,1987 *** REVIEWS *** TOXICOLOGY REVIEW JRPMAP Journal of Reproductive Medicine. (2 Jacklynn Ct., St. Louis, MO 63132) V.3- 1969- Volume(issue)/page/year: 12,27,1974 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X3669 No. of Facilities: 98 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 1754 (estimated) No. of Female Employees: 962 (estimated)
|
Safety Information
| Symbol | GHS07 |
|---|
| Signal Word | Warning |
|---|
| Hazard Statements | H302 |
|---|
| Precautionary Statements | P301 + P312 + P330 |
|---|
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|
| Hazard Codes | Xn:Harmful |
|---|
| Risk Phrases | R22 |
|---|
| Safety Phrases | 22-26-36/37/39-53 |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| WGK Germany | 3 |
|---|
| RTECS | XH5082000 |
|---|
| HS Code | 2933990090 |
|---|
Customs
| HS Code | 2933990090 |
|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Articles29
More Articles
| Individualizing oral busulfan dose after using a test dose in patients undergoing hematopoietic stem cell transplantation: pharmacokinetic characterization. Ther. Drug Monit. 37(1) , 66-70, (2015) Busulfan is an alkylating agent used for conditioning patients undergoing hematopoietic stem cell transplantation with a narrow therapeutic range and highly variable pharmacokinetics. High concentrati... | |
| Nausea and vomiting in pregnancy: a review of the pathology and compounding opportunities. Int. J. Pharm. Compd. 17(2) , 113-23, (2013) Nausea and vomiting in pregnancy can have serious adverse effects on the quality of a woman's life, affecting her occupational, social, and domestic functioning, and her general well-being; therefore,... | |
| Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neurosci. Biobehav. Rev. 26(1) , 61-7, (2002) The over-the-counter anti-emetic dimenhydrinate (DMH) (Gravol or Dramamine) has been reported to be abused for non-medicinal purposes. Street drug users abuse DMH for the acute effects of euphoric sen... | |
Synonyms
| faston |
| dromyl |
| N-(2-Diphenylmethoxyethyl)-N,N-dimethylammonium 8-chlorotheophyllinate |
| 8-Chlor-1,3-dimethyl-3,7-dihydro-purin-2,6-dion,Verbindung mit (2-Benzhydryloxy-aethyl)-dimethyl-amin |
| gravol |
| epha |
| EINECS 208-350-8 |
| vomexa |
| amosyt |
| MFCD00054265 |
| emedyl |
| dramyl |
| emes |
| Dimenhydrinate |
| 8-chloro-1,3-dimethyl-3,7-dihydro-purine-2,6-dione,compound with (2-benzhydryloxy-ethyl)-dimethyl-amine |
| Dimenhydrinase |
| DiMate |